Runx2 was shown to be more specifically expressed in activated HSCs in NAFLD mice, which can modulate the expression of monocyte chemotactic protein 1 (MCP-1) to increase liver infiltration of macrophages [83]. Here, CCL2 is linked to metabolic dysfunction-associated steatotic liver disease.